Paper3947503
Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative.
Vital Durand D and 4 others. Br J Clin Pharmacol, 1986. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative. Papers, record 3947503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3947503
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mixed Function Oxygenases | Major topic |
| Rifampin | Major topic |
| Adult | |
| Antipyrine | |
| Biotransformation | |
| Enzyme Induction | |
| Half-Life | |
| Humans | |
| Hydrocortisone | |
| Male | |
| Saliva | |
| Time Factors |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4723259 | Dose-dependent enzyme induction. | Clin Pharmacol Ther | 1973 | https://conductscience.org/library/papers/4723259 | PubMed |
| 2 | 6508979 | Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6508979 | PubMed |
| 3 | 4593769 | The effect of spironolactone on antipyrine metabolism in man. | Pharmacology | 1973 | https://conductscience.org/library/papers/4593769 | PubMed |
| 4 | 973966 | Assessment of antipyrine kinetics by measurement in saliva. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/973966 | PubMed |
| 5 | 849823 | Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. | Gastroenterology | 1977 | https://conductscience.org/library/papers/849823 | PubMed |
| 6 | 140033 | Pharmacokinetic interactions with rifampicin. | Clin Pharmacokinet | 1977 | https://conductscience.org/library/papers/140033 | PubMed |
| 7 | 728306 | Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/728306 | PubMed |
| 8 | 745397 | A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine. | J Steroid Biochem | 1978 | https://conductscience.org/library/papers/745397 | PubMed |
| 9 | 111889 | The antipyrine test in clinical pharmacology: conceptions and misconceptions. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/111889 | PubMed |
| 10 | 480161 | High-pressure liquid chromatographic analysis of antipyrine in small plasma samples. | J Pharm Sci | 1979 | https://conductscience.org/library/papers/480161 | PubMed |
| 11 | 533575 | Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/533575 | PubMed |
| 12 | 522906 | 4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man. | Naunyn Schmiedebergs Arch Pharmacol | 1979 | https://conductscience.org/library/papers/522906 | PubMed |
| 13 | 6113907 | Clinical implications of enzyme induction and enzyme inhibition. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/6113907 | PubMed |
| 14 | 6791958 | Method for determination of DL 473-IT and its metabolite L 14583 in plasma of humans, monkeys and rats. | Farmaco Prat | 1981 | https://conductscience.org/library/papers/6791958 | PubMed |
| 15 | 7028436 | Metabolism and pharmacokinetics of the antibiotic rifampin. | Drug Metab Rev | 1981 | https://conductscience.org/library/papers/7028436 | PubMed |
| 16 | 7059439 | Effect of rifampicin on metoprolol and antipyrine kinetics. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7059439 | PubMed |
| 17 | 7341283 | Differential induction of antipyrine metabolism by rifampicin. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7341283 | PubMed |
| 18 | 7075648 | Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7075648 | PubMed |
| 19 | 6627809 | Interindividual variations in drug disposition. Clinical implications and methods of investigation. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6627809 | PubMed |
| 20 | 6668316 | Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine. | J Chromatogr | 1983 | https://conductscience.org/library/papers/6668316 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25512422 | Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25512422 | PubMed |
| 22472995 | Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22472995 | PubMed |
| 15762766 | Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15762766 | PubMed |
| 14605790 | Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. | Eur J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/14605790 | PubMed |
| 10628899 | Cytochrome P450 3A: ontogeny and drug disposition. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10628899 | PubMed |
| 9806107 | Rifapentine. | Drugs | 1998 | https://conductscience.org/library/papers/9806107 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3947503
GET https://conductscience.org/api/papers/v1/3947503/references?page=2